Jane Street’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-984
| Closed | -$6.62K | – | 6489 |
|
|
2023
Q4 | $6.62K | Buy |
984
+493
| +100% | +$3.32K | ﹤0.01% | 5582 |
|
|
2023
Q3 | $4.49K | Sell |
491
-716
| -59% | -$6.55K | ﹤0.01% | 5010 |
|
|
2023
Q2 | $25.5K | Sell |
1,207
-682
| -36% | -$14.4K | ﹤0.01% | 5040 |
|
|
2023
Q1 | $50.8K | Buy |
1,889
+1,429
| +311% | +$38.4K | ﹤0.01% | 5112 |
|
|
2022
Q4 | $16.3K | Buy |
+460
| New | +$16.3K | ﹤0.01% | 5104 |
|
|
2022
Q3 | – | Sell |
-873
| Closed | -$165K | – | 6519 |
|
|
2022
Q2 | $165K | Buy |
+873
| New | +$165K | ﹤0.01% | 4550 |
|
|
2022
Q1 | – | Sell |
-3,042
| Closed | -$474K | – | 6342 |
|
|
2021
Q4 | $474K | Buy |
3,042
+790
| +35% | +$123K | ﹤0.01% | 3529 |
|
|
2021
Q3 | $451K | Buy |
+2,252
| New | +$451K | ﹤0.01% | 3550 |
|
|
2019
Q1 | – | Sell |
-375
| Closed | -$114K | – | 3875 |
|
|
2018
Q4 | $114K | Buy |
+375
| New | +$114K | ﹤0.01% | 2931 |
|